维普中文期刊产品整合服务
22篇 您的检索式:作者名="Valerius T"
    题名 作者 年代 出处 被引量
1Intrinsic epithelialcells repair the kidney after injury显示文摘Humphreys B D Valerius M T Kobayashi A MugfordJ W Soeung S Duffield J S 2008Cell Stem Cell2008,2,:1
2FcαRI (CD89) as a novel trigger molecule for bispecific antibody therapy显示文摘Valerius T Stochemeyer B van Spriel AB 1997Blood1997,90,11:1
3Neutrophils express the high affinity receptor for IgG (Fc gamma RI, CI)64 ) after in vivo application of recombinant human granulocyte colony-stimulating factor 显示文摘Repp R Valerius T Sendler A 1991Blood1991,78,4:1
4Boosting ADCC and CDC activity by Fc engineering and evaluation of anti- body effector functions 显示文摘Kellner C Derer S Valerius T 2014Methods2014,65,1:1
5Bispecific antibodies targeting cancer ceils显示文摘Peipp M Valerius T 2002Biochem Soc Trans2002,30,4:1
6Bispecific antibodies targeting cancer cells显示文摘Peipp M Valerius T 2002Biochem Soc Trans2002,30,4:1
7Recent genetic studies of mouse kidney development 显示文摘Yu J Mcmahon A P Valerius M T 2004Curr Opin Genet Dev2004,14,:1
8Neuropsychologi cal and cerebral morphometric aspects of negative symptoms in schizophrenia: negative symptomalology is associated with specific nmestic deficits in schizophrenic palients 显示文摘Hornig T Valerius G Feige B 2014BMC Psychiatry2014,14,1:1
9Notch pathway activation can replace the requirement for Wnt4 amt Wnt9b in mesenchymal-to-epithelial transition of nephron stem cells 显示文摘Boyle SC Kim M Valerius M T 2011Development2011,138,19:1
10Precliniucal and clinical data vith bispecific antibodies recruiting myeloid effector cells for tumor therapy显示文摘Van ojik H H Valerius T 2001Crit Rev Oncol Hematol2001,,38:1
11Six2 defines and regulates a multipotent self - renewing nephron progenitor popula- tion throughout mammalian kidney development 显示文摘Kobayashi A Valerius M T Mugford J W 2008Cell Stem Cell2008,3,2:1
12Analysis of early nephron patterning reveals a role for distal RV proliferation in fu- sion to the ureterie tip via a cap mesenchyme - derived connecting segment显示文摘Georgas K Rumballe B Valerius M T 2009Developmental biology2009,332,2:1
13Monoclonal antibodies for the treatment of cancer:Reality and future directions enhancer显示文摘Dechant M Valerius T 2005Biotherapy of Cancer2005,3,2:1
14FcαRI(CD89)as a novel trigger molecule for bispecific antibody therapy显示文摘Valerius T Stockmeyer B Van Spriel AB 1997Blood1997,90,11:1
15Codon optimization for high level expression of human bone morphogenetic protein-2 in Escherichia coli 显示文摘Debbie S R Pramesti H T Santika P Y Valerius O Asjarie S S 2012Protein Expression and Purification2012,84,:1
16Preclinical and clinical data with bispecific antibodies recruiting myeloid effector cells for tumor therapy显示文摘Van Ojik HH Valerius T 2001Crit Rev Oncol Hematol2001,,38:1
17Preclinical and clinical data vith bispecific antibodies recruiting myeloid effector cells for tumor therapy显示文摘Van O H H Valerius T 2001Crit Rev Oncol Hematol2001,,38:1
18Preclinical and clinical data with bispecific antibodies recruiting myeloid effector cells for tumor therapy 显示文摘van Ojik HH Valerius T 2001Crit Rev Oncol/Hematol2001,38,:1
19Phase Ⅰ clinical trial of the bispecific antibody MDX-H210(anti-Fc gamma RI xanti-HER27neu)in combination with Filgrastim (G-csf) for treatment of advanced breast cancer显示文摘Repp R van Ojik HH Valerius T 2003Br J Cancer2003,89,12:1
20In- trinsic epithelial ceils repair the kidney after injury显示文摘HUMPHREYS B D VALERIUS M T KOBAYASHI A 2008Cell stem cell2008,2,3:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费